These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 15832972
1. [The study of two immunological markers in patients with type-1 diabetes and in their first degree relatives]. Cosmescu A, Graur M, Zlei M, Mătăsaru S, Felea D, Petroaie A, Slanină AM, Barbacariu L, Momanu O. Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):549-53. PubMed ID: 15832972 [Abstract] [Full Text] [Related]
2. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF. J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [Abstract] [Full Text] [Related]
3. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population. Krochik AG, Mazza CS, Valdez SN, Stumpo RR, Papouchado ML, Iacono RF, Cardoso Landaburu AC, Sica MP, Ozuna B, Poskus E. Medicina (B Aires); 2001 Dec; 61(3):279-83. PubMed ID: 11474874 [Abstract] [Full Text] [Related]
4. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus. Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG. Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966 [Abstract] [Full Text] [Related]
5. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model. Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG. Exp Clin Endocrinol Diabetes; 1999 Oct; 107(8):496-505. PubMed ID: 10612480 [Abstract] [Full Text] [Related]
6. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J. J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299 [Abstract] [Full Text] [Related]
9. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper. Siraj ES, Rogers DG, Gupta MK, Reddy SS. Horm Metab Res; 2012 Oct; 44(11):855-60. PubMed ID: 22893260 [Abstract] [Full Text] [Related]
10. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T. J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433 [Abstract] [Full Text] [Related]
12. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935 [Abstract] [Full Text] [Related]
13. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group. Seissler J, Atik Y, Klinghammer A, Scherbaum WA. Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918 [Abstract] [Full Text] [Related]
14. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? Schmidli RS, Colman PG, Harrison LC. J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043 [Abstract] [Full Text] [Related]
15. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease]. Schilling I, Conrad K, Füssel M, Henker J. Dtsch Med Wochenschr; 2003 Jan 31; 128(5):185-9. PubMed ID: 12557109 [Abstract] [Full Text] [Related]